{
    "title": "103_s1429",
    "content": "The Act titled \"Women and AIDS Research Initiative Amendments of 1993\" establishes a program for research on women and AIDS. This includes a new section on research regarding women in the Public Health Service Act. The Secretary will establish a program for biomedical and behavioral research on HIV cases in women, including prevention research. This includes studying HIV transmission, relationship with other STDs, clinical trials on preventing HIV through treating STDs, and measures to prevent virus exposure and transmission. The program for biomedical and behavioral research on HIV in women includes studying transmission, prevention of sexually transmitted diseases, rapid diagnostic tests, single-dose therapy, prevention methods for women, development of prevention programs, symptoms progression, gynecological infections, breast changes, hormonal changes, menopause changes, and treatment of HIV cases. The program for biomedical and behavioral research on HIV in women includes studying transmission, prevention of sexually transmitted diseases, rapid diagnostic tests, single-dose therapy, prevention methods, development of prevention programs, symptoms progression, gynecological infections, breast changes, hormonal changes, menopause changes, treatment of HIV cases, and clinical trials focusing on gynecological evaluations for female subjects infected with HIV. The Secretary conducts clinical trials to determine the effectiveness of standard treatments for gynecological conditions arising from HIV infection. Additionally, trials are conducted to assess the effectiveness of treatment protocols approved for men on women with HIV. Support services such as transportation and child care are provided to women participating in clinical trials under this program. The Secretary provides women participating in clinical trials with transportation, child care, and support services including medical, mental health, drug abuse treatment, and services addressing domestic violence. Services are tailored to meet the specific needs of women in clinical trials, with a focus on training for trial conductors. Research is conducted on barrier methods for preventing sexually transmitted diseases, including HIV transmission. The Secretary prioritizes research on barrier methods for preventing sexually transmitted diseases, including HIV, that women can use independently. This includes research on early infectious stages, formulation of new preparations, clinical testing, and studies on acceptability and compliance. Additionally, the Secretary conducts epidemiological research. The Secretary conducts epidemiological research to determine risk factors for HIV infection in women, including contraceptive methods, tampon use, STDs, substance abuse, and sexual activity. Additionally, an interagency study is being carried out to monitor HIV progression in women. The Women's Interagency HIV Study aims to monitor HIV progression in women, with a focus on CD4 cell count and the development of serious illnesses. The study includes at least 5,000 women with HIV, spans a minimum of 8 years, and addresses gynecological and other conditions specific to women. The text chunk discusses conditions specific to women related to HIV infection that are not currently included in the CDC's surveillance list. It also defines HIV as the cause of AIDS and authorizes appropriations for clinical trials related to HIV research. For fiscal years 1994 through 1996, appropriations are authorized for various subsections related to HIV prevention programs, totaling $65 million. For fiscal years 1994 through 1996, appropriations totaling $25 million are authorized for interagency studies related to HIV prevention programs."
}